CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 145 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 1.85 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,841,175 | +47.3% | 157,500 | +69.4% | 0.35% | +52.6% |
| Q2 2023 | $1,249,920 | -18.9% | 93,000 | 0.0% | 0.23% | -5.0% |
| Q1 2023 | $1,541,940 | +33.7% | 93,000 | +50.0% | 0.24% | +28.7% |
| Q4 2022 | $1,153,200 | +45.1% | 62,000 | 0.0% | 0.19% | +37.2% |
| Q3 2022 | $795,000 | -12.7% | 62,000 | -52.3% | 0.14% | -12.7% |
| Q2 2022 | $911,000 | +61.5% | 130,000 | +91.2% | 0.16% | +42.7% |
| Q1 2022 | $564,000 | +22.6% | 68,000 | 0.0% | 0.11% | +8.9% |
| Q4 2021 | $460,000 | -30.0% | 68,000 | -45.2% | 0.10% | -30.3% |
| Q3 2021 | $657,000 | -7.9% | 124,000 | 0.0% | 0.14% | -2.0% |
| Q2 2021 | $713,000 | – | 124,000 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 208,189 | $1,726,000 | 3.48% |
| FRIESS ASSOCIATES LLC | 571,940 | $4,741,000 | 2.53% |
| GABLES CAPITAL MANAGEMENT INC. | 438,764 | $3,637,000 | 2.28% |
| Prairiewood Capital, LLC | 258,073 | $2,139,000 | 1.50% |
| Quantedge Capital Pte Ltd | 597,300 | $4,952,000 | 1.46% |
| ARMISTICE CAPITAL, LLC | 8,372,000 | $69,404,000 | 1.34% |
| SummerHaven Investment Management, LLC | 158,473 | $1,314,000 | 0.74% |
| Capital Impact Advisors, LLC | 99,322 | $823,000 | 0.60% |
| EAM Investors, LLC | 365,415 | $3,029,000 | 0.56% |
| GLOBEFLEX CAPITAL L P | 304,515 | $2,524,000 | 0.51% |